Amgen (AMGN) Misses Q4 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Amgen (AMGN) PT Raised to $205 at Bernstein Following 4Q
February 2, 2018 8:06 AM ESTBernstein raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $189.00) while maintaining a Market Perform rating following the company's 4Q earnings report. Amgen missed a bit on top line with a bit more of a material miss on EPS ($5,602, -0.7%; $2.89, -14c). The... More
Amgen (AMGN) PT Lowered to $196 at Morgan Stanley
February 2, 2018 6:56 AM ESTMorgan Stanley lowered its price target on Amgen (NASDAQ: AMGN) to $196.00 (from $204.00) while maintaining a Overweight rating.
... MoreAmgen (AMGN) PT Raised to $224 at Oppenheimer
February 2, 2018 6:54 AM ESTOppenheimer raised its price target on Amgen (NASDAQ: AMGN) to $224.00 (from $205.00) while maintaining an Outperform rating.
Analyst Leah Rush Cann commented, "Amgen reported GAAP earnings per share, before a one-time tax-reform charge, of $2.70, which is 9.2% lower than our estimate of $2.97. Earnings were... More
